Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07401771

Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent obtained
  • Three groups will be enrolled:
  • HFpEF (cardiologist-adjudicated diagnosis as verified by PI, EF≥50%)
  • Non-cardiac dyspnea (patients have dyspnea but were found on invasive exercise testing not to have HFpEF).
  • Healthy volunteers with no history of dyspnea or effort intolerance.

Exclusion criteria

  • Contraindication for low-field CMR, as indicated in MRI safety screening checklist (Research Document #1)
  • Patient inability or unwillingness to undergo Ex-CMR
  • Cardiac implants, mechanical or biological valve, causing artifacts that compromise the quality of data
  • Hospitalization for heart failure in the preceding 30 days.
  • Large R-R interval variation, caused by frequent premature ventricular contractions or non-sinus rhythms such as persistent atrial fibrillation, which, in the opinion of the investigators, compromises the quality of data acquisition, image analysis and disrupts the consistency of the cohorts
  • Myocardial infarction or unstable angina pectoris
  • Planned coronary, carotid, or peripheral artery revascularization
  • Other causes of dyspnea as indicated in patients' medical history based upon the opinion of the PI, such as restrictive cardiomyopathy or infiltrative conditions (e.g., amyloidosis), hypertrophic obstructive cardiomyopathy, primary pulmonary arterial hypertension, more than moderate chronic obstructive pulmonary disease, right heart failure due to pulmonary disease, complex congenital heart disease, severe anemia, or more than moderate mitral or aortic heart valve disease).

Treatment and study plan

Exercise Cardiovascular Magnetic Resonance

Diagnostic Test

Exercise Cardiovascular Magnetic Resonance is a non-invasive imaging technique that combines cardiovascular magnetic resonance (CMR) with exercise stress testing.

Primary outcomes

  1. Number of heart failure hospitalizations

    Time frame: Baseline

    Number of heart failure hospitalizations will be determined by the number of patients admitted to the hospital due to heart failure complications.

  2. Number of cardiac deaths

    Time frame: Baseline

    The number of cardiac deaths will include all patients whose death is attributable to a cardiac cause.

Secondary outcomes

  1. Number of deaths

    Time frame: Baseline

    The number of deaths will include all patient deaths, regardless of cause.

Study contacts

Contact information is provided by the study sponsor or research team.

Annabelle Fuenffinger

CONTACT

[email protected]

507-422-3801

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Feb 10, 2026
Registry last updated
Apr 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.